Sexual Dysfunction. Sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Intervention 1: Rosafeel Barij, soft capsule containing 15 mg of Rose essential oil (standard on the basis of at least 5/7 mg per capsule citronellol) twice a day for 8 weeks. Intervention 2: Placebo
Treatment - Drugs
Placebo
Rosafeel Barij, soft capsule containing 15 mg of Rose essential oil (standard on the basis of at least 5/7 mg per capsule citronellol) twice a day for 8 weeks.
Placebo, soft capsules, containing Sesame oil or soy, twice a day for 8 weeks.
Sponsors
Barij Essence Pharmaceutical companies
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria included all the married women have a stable life with wife, At least read and write, Not during pregnancy and lactation and menopause, Without having any chronic disease(self reported), Absence of mental illness known -Psychic(self reported), Non-hormonal drugs and drugs that affect sexual desire and performance(Such as antidepressants, aspirin and anticoagulants), According to the questionnaire, the Female Sexual Function Index (FSFI) questionnaire impaired sexual function, according to Beck (BDI) is a non-depressive illness, Is not a multi-partner, The lack of adverse events in at least 6 months, Lack of substance abuse and alcohol in a person and The absence of a partner's sexual dysfunction (premature ejaculation, erectile dysfunction) self-reported is. Exclusion criteria included Not wanting to continue to participate in research, Lack of sex during the study, Drugs only affect sexual function during the study, Diagnosis of chronic disease and mental - mental in person during the period of study( self-reported), No drug or placebo for a week or more and Disasters like the loss of a spouse or close relative during the study period.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before the intervention, 4 weeks after starting treatment and after the treatment at week 8. Method of measurement: FSFI Standardized questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadeseh motaharinezhad
school of midwifery and nursing, Tehran university of medical science
Outcome results
None listed